No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Bronchopulmonary Dysplasia (BPD)
Interventions
DRUG

Oral ibuprofen

Initial dose of 10 mg/kg of oral ibuprofen, followed by two doses of 5 mg/kg 24 and 48 hours later

DRUG

Normal saline

Initial dose of normal saline followed by second and third dose 24 and 48 hours later, at equal volume to ibuprofen arm

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02128191 - No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants | Biotech Hunter | Biotech Hunter